nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Estradiol—osteoporosis	0.0578	0.162	CbGbCtD
Vardenafil—CYP3A4—Estropipate—osteoporosis	0.0542	0.152	CbGbCtD
Vardenafil—CYP3A4—Calcitriol—osteoporosis	0.0542	0.152	CbGbCtD
Vardenafil—CYP3A4—Ergocalciferol—osteoporosis	0.0434	0.122	CbGbCtD
Vardenafil—CYP3A4—Raloxifene—osteoporosis	0.0362	0.101	CbGbCtD
Vardenafil—CYP3A4—Ethinyl Estradiol—osteoporosis	0.035	0.0979	CbGbCtD
Vardenafil—CYP3A4—Cholecalciferol—osteoporosis	0.0279	0.0783	CbGbCtD
Vardenafil—CYP3A4—Conjugated Estrogens—osteoporosis	0.0257	0.0719	CbGbCtD
Vardenafil—CYP3A4—Estradiol—osteoporosis	0.0225	0.0631	CbGbCtD
Vardenafil—Rhinitis—Estradiol—osteoporosis	0.000419	0.000932	CcSEcCtD
Vardenafil—Haemorrhage—Estradiol—osteoporosis	0.000418	0.00093	CcSEcCtD
Vardenafil—Palpitations—Zoledronate—osteoporosis	0.000417	0.000928	CcSEcCtD
Vardenafil—Abdominal pain—Calcitriol—osteoporosis	0.000417	0.000927	CcSEcCtD
Vardenafil—Hypoaesthesia—Estradiol—osteoporosis	0.000416	0.000925	CcSEcCtD
Vardenafil—Angioedema—Conjugated Estrogens—osteoporosis	0.000416	0.000924	CcSEcCtD
Vardenafil—Shock—Pamidronate—osteoporosis	0.000415	0.000923	CcSEcCtD
Vardenafil—Loss of consciousness—Zoledronate—osteoporosis	0.000415	0.000923	CcSEcCtD
Vardenafil—Pharyngitis—Estradiol—osteoporosis	0.000415	0.000923	CcSEcCtD
Vardenafil—Hypersensitivity—Estropipate—osteoporosis	0.000414	0.00092	CcSEcCtD
Vardenafil—Nervous system disorder—Pamidronate—osteoporosis	0.000414	0.00092	CcSEcCtD
Vardenafil—Urinary tract disorder—Estradiol—osteoporosis	0.000413	0.000918	CcSEcCtD
Vardenafil—Vomiting—Etidronic acid—osteoporosis	0.000413	0.000918	CcSEcCtD
Vardenafil—Tachycardia—Pamidronate—osteoporosis	0.000412	0.000916	CcSEcCtD
Vardenafil—Connective tissue disorder—Estradiol—osteoporosis	0.000411	0.000914	CcSEcCtD
Vardenafil—Urethral disorder—Estradiol—osteoporosis	0.00041	0.000911	CcSEcCtD
Vardenafil—Rash—Etidronic acid—osteoporosis	0.000409	0.00091	CcSEcCtD
Vardenafil—Convulsion—Zoledronate—osteoporosis	0.000409	0.00091	CcSEcCtD
Vardenafil—Dermatitis—Etidronic acid—osteoporosis	0.000409	0.00091	CcSEcCtD
Vardenafil—Vertigo—Conjugated Estrogens—osteoporosis	0.000409	0.000909	CcSEcCtD
Vardenafil—Hyperhidrosis—Pamidronate—osteoporosis	0.000408	0.000907	CcSEcCtD
Vardenafil—Syncope—Conjugated Estrogens—osteoporosis	0.000408	0.000907	CcSEcCtD
Vardenafil—Hypersensitivity—Alendronate—osteoporosis	0.000408	0.000906	CcSEcCtD
Vardenafil—Headache—Etidronic acid—osteoporosis	0.000407	0.000905	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000404	0.000899	CcSEcCtD
Vardenafil—Asthenia—Estropipate—osteoporosis	0.000403	0.000896	CcSEcCtD
Vardenafil—Visual impairment—Estradiol—osteoporosis	0.000403	0.000896	CcSEcCtD
Vardenafil—Chest pain—Zoledronate—osteoporosis	0.000402	0.000894	CcSEcCtD
Vardenafil—Arthralgia—Zoledronate—osteoporosis	0.000402	0.000894	CcSEcCtD
Vardenafil—Myalgia—Zoledronate—osteoporosis	0.000402	0.000894	CcSEcCtD
Vardenafil—Palpitations—Conjugated Estrogens—osteoporosis	0.000402	0.000894	CcSEcCtD
Vardenafil—Insomnia—Risedronate—osteoporosis	0.000402	0.000893	CcSEcCtD
Vardenafil—Anxiety—Zoledronate—osteoporosis	0.000401	0.000891	CcSEcCtD
Vardenafil—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.0004	0.000889	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000399	0.000888	CcSEcCtD
Vardenafil—Paraesthesia—Risedronate—osteoporosis	0.000399	0.000886	CcSEcCtD
Vardenafil—Pruritus—Estropipate—osteoporosis	0.000397	0.000884	CcSEcCtD
Vardenafil—Discomfort—Zoledronate—osteoporosis	0.000397	0.000883	CcSEcCtD
Vardenafil—Asthenia—Alendronate—osteoporosis	0.000397	0.000883	CcSEcCtD
Vardenafil—Hypersensitivity—Ibandronate—osteoporosis	0.000397	0.000882	CcSEcCtD
Vardenafil—Dyspnoea—Risedronate—osteoporosis	0.000396	0.00088	CcSEcCtD
Vardenafil—Hypotension—Pamidronate—osteoporosis	0.000394	0.000877	CcSEcCtD
Vardenafil—Convulsion—Conjugated Estrogens—osteoporosis	0.000394	0.000876	CcSEcCtD
Vardenafil—Dry mouth—Zoledronate—osteoporosis	0.000393	0.000874	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000393	0.000874	CcSEcCtD
Vardenafil—Pruritus—Alendronate—osteoporosis	0.000391	0.00087	CcSEcCtD
Vardenafil—Dyspepsia—Risedronate—osteoporosis	0.000391	0.000869	CcSEcCtD
Vardenafil—Eye disorder—Estradiol—osteoporosis	0.000391	0.000869	CcSEcCtD
Vardenafil—Tinnitus—Estradiol—osteoporosis	0.00039	0.000867	CcSEcCtD
Vardenafil—Hypersensitivity—Calcitriol—osteoporosis	0.000389	0.000864	CcSEcCtD
Vardenafil—Cardiac disorder—Estradiol—osteoporosis	0.000388	0.000863	CcSEcCtD
Vardenafil—Flushing—Estradiol—osteoporosis	0.000388	0.000863	CcSEcCtD
Vardenafil—Chest pain—Conjugated Estrogens—osteoporosis	0.000387	0.000861	CcSEcCtD
Vardenafil—Myalgia—Conjugated Estrogens—osteoporosis	0.000387	0.000861	CcSEcCtD
Vardenafil—Arthralgia—Conjugated Estrogens—osteoporosis	0.000387	0.000861	CcSEcCtD
Vardenafil—Asthenia—Ibandronate—osteoporosis	0.000387	0.000859	CcSEcCtD
Vardenafil—Anxiety—Conjugated Estrogens—osteoporosis	0.000386	0.000858	CcSEcCtD
Vardenafil—Nausea—Etidronic acid—osteoporosis	0.000386	0.000858	CcSEcCtD
Vardenafil—Anaphylactic shock—Zoledronate—osteoporosis	0.000386	0.000857	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000385	0.000855	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000385	0.000855	CcSEcCtD
Vardenafil—Diarrhoea—Estropipate—osteoporosis	0.000384	0.000855	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Risedronate—osteoporosis	0.000383	0.000852	CcSEcCtD
Vardenafil—Infection—Zoledronate—osteoporosis	0.000383	0.000852	CcSEcCtD
Vardenafil—Insomnia—Pamidronate—osteoporosis	0.000382	0.000849	CcSEcCtD
Vardenafil—Pruritus—Ibandronate—osteoporosis	0.000381	0.000847	CcSEcCtD
Vardenafil—Pain—Risedronate—osteoporosis	0.00038	0.000844	CcSEcCtD
Vardenafil—Angiopathy—Estradiol—osteoporosis	0.000379	0.000844	CcSEcCtD
Vardenafil—Shock—Zoledronate—osteoporosis	0.000379	0.000843	CcSEcCtD
Vardenafil—Paraesthesia—Pamidronate—osteoporosis	0.000379	0.000843	CcSEcCtD
Vardenafil—Diarrhoea—Alendronate—osteoporosis	0.000379	0.000842	CcSEcCtD
Vardenafil—Asthenia—Calcitriol—osteoporosis	0.000378	0.000841	CcSEcCtD
Vardenafil—Nervous system disorder—Zoledronate—osteoporosis	0.000378	0.000841	CcSEcCtD
Vardenafil—Immune system disorder—Estradiol—osteoporosis	0.000378	0.00084	CcSEcCtD
Vardenafil—Mediastinal disorder—Estradiol—osteoporosis	0.000377	0.000838	CcSEcCtD
Vardenafil—Dyspnoea—Pamidronate—osteoporosis	0.000376	0.000837	CcSEcCtD
Vardenafil—Tachycardia—Zoledronate—osteoporosis	0.000376	0.000837	CcSEcCtD
Vardenafil—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000375	0.000834	CcSEcCtD
Vardenafil—Somnolence—Pamidronate—osteoporosis	0.000375	0.000834	CcSEcCtD
Vardenafil—Skin disorder—Zoledronate—osteoporosis	0.000374	0.000833	CcSEcCtD
Vardenafil—Pruritus—Calcitriol—osteoporosis	0.000373	0.00083	CcSEcCtD
Vardenafil—Hyperhidrosis—Zoledronate—osteoporosis	0.000373	0.000829	CcSEcCtD
Vardenafil—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000372	0.000828	CcSEcCtD
Vardenafil—Diarrhoea—Raloxifene—osteoporosis	0.000372	0.000828	CcSEcCtD
Vardenafil—Dyspepsia—Pamidronate—osteoporosis	0.000372	0.000826	CcSEcCtD
Vardenafil—Dizziness—Estropipate—osteoporosis	0.000371	0.000826	CcSEcCtD
Vardenafil—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000371	0.000825	CcSEcCtD
Vardenafil—Infection—Conjugated Estrogens—osteoporosis	0.000369	0.00082	CcSEcCtD
Vardenafil—Diarrhoea—Ibandronate—osteoporosis	0.000369	0.00082	CcSEcCtD
Vardenafil—Mental disorder—Estradiol—osteoporosis	0.000366	0.000815	CcSEcCtD
Vardenafil—Dizziness—Alendronate—osteoporosis	0.000366	0.000814	CcSEcCtD
Vardenafil—Shock—Conjugated Estrogens—osteoporosis	0.000365	0.000812	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000364	0.00081	CcSEcCtD
Vardenafil—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000364	0.000809	CcSEcCtD
Vardenafil—Erythema—Estradiol—osteoporosis	0.000364	0.000809	CcSEcCtD
Vardenafil—Gastrointestinal pain—Risedronate—osteoporosis	0.000363	0.000807	CcSEcCtD
Vardenafil—Tachycardia—Conjugated Estrogens—osteoporosis	0.000362	0.000806	CcSEcCtD
Vardenafil—Pain—Pamidronate—osteoporosis	0.000361	0.000802	CcSEcCtD
Vardenafil—Diarrhoea—Calcitriol—osteoporosis	0.000361	0.000802	CcSEcCtD
Vardenafil—Skin disorder—Conjugated Estrogens—osteoporosis	0.000361	0.000802	CcSEcCtD
Vardenafil—Hypotension—Zoledronate—osteoporosis	0.00036	0.000801	CcSEcCtD
Vardenafil—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00036	0.0008	CcSEcCtD
Vardenafil—Dizziness—Raloxifene—osteoporosis	0.00036	0.0008	CcSEcCtD
Vardenafil—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000359	0.000798	CcSEcCtD
Vardenafil—Vomiting—Estropipate—osteoporosis	0.000357	0.000794	CcSEcCtD
Vardenafil—Dizziness—Ibandronate—osteoporosis	0.000356	0.000792	CcSEcCtD
Vardenafil—Rash—Estropipate—osteoporosis	0.000354	0.000788	CcSEcCtD
Vardenafil—Dermatitis—Estropipate—osteoporosis	0.000354	0.000787	CcSEcCtD
Vardenafil—Back pain—Estradiol—osteoporosis	0.000352	0.000783	CcSEcCtD
Vardenafil—Headache—Estropipate—osteoporosis	0.000352	0.000783	CcSEcCtD
Vardenafil—Vomiting—Alendronate—osteoporosis	0.000352	0.000782	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000351	0.000781	CcSEcCtD
Vardenafil—Abdominal pain—Risedronate—osteoporosis	0.000351	0.00078	CcSEcCtD
Vardenafil—Muscle spasms—Estradiol—osteoporosis	0.00035	0.000778	CcSEcCtD
Vardenafil—Rash—Alendronate—osteoporosis	0.000349	0.000776	CcSEcCtD
Vardenafil—Insomnia—Zoledronate—osteoporosis	0.000349	0.000775	CcSEcCtD
Vardenafil—Dermatitis—Alendronate—osteoporosis	0.000349	0.000775	CcSEcCtD
Vardenafil—Feeling abnormal—Pamidronate—osteoporosis	0.000348	0.000773	CcSEcCtD
Vardenafil—Hypotension—Conjugated Estrogens—osteoporosis	0.000347	0.000771	CcSEcCtD
Vardenafil—Headache—Alendronate—osteoporosis	0.000347	0.000771	CcSEcCtD
Vardenafil—Paraesthesia—Zoledronate—osteoporosis	0.000346	0.00077	CcSEcCtD
Vardenafil—Vomiting—Raloxifene—osteoporosis	0.000346	0.000769	CcSEcCtD
Vardenafil—Gastrointestinal pain—Pamidronate—osteoporosis	0.000345	0.000767	CcSEcCtD
Vardenafil—Dyspnoea—Zoledronate—osteoporosis	0.000344	0.000764	CcSEcCtD
Vardenafil—Rash—Raloxifene—osteoporosis	0.000343	0.000763	CcSEcCtD
Vardenafil—Dermatitis—Raloxifene—osteoporosis	0.000343	0.000762	CcSEcCtD
Vardenafil—Somnolence—Zoledronate—osteoporosis	0.000343	0.000762	CcSEcCtD
Vardenafil—Vomiting—Ibandronate—osteoporosis	0.000343	0.000762	CcSEcCtD
Vardenafil—Headache—Raloxifene—osteoporosis	0.000341	0.000758	CcSEcCtD
Vardenafil—Rash—Ibandronate—osteoporosis	0.00034	0.000755	CcSEcCtD
Vardenafil—Dermatitis—Ibandronate—osteoporosis	0.000339	0.000755	CcSEcCtD
Vardenafil—Dyspepsia—Zoledronate—osteoporosis	0.000339	0.000755	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000338	0.000752	CcSEcCtD
Vardenafil—Ill-defined disorder—Estradiol—osteoporosis	0.000338	0.000751	CcSEcCtD
Vardenafil—Headache—Ibandronate—osteoporosis	0.000337	0.00075	CcSEcCtD
Vardenafil—Insomnia—Conjugated Estrogens—osteoporosis	0.000336	0.000746	CcSEcCtD
Vardenafil—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000335	0.000746	CcSEcCtD
Vardenafil—Vomiting—Calcitriol—osteoporosis	0.000335	0.000746	CcSEcCtD
Vardenafil—Nausea—Estropipate—osteoporosis	0.000334	0.000742	CcSEcCtD
Vardenafil—Abdominal pain—Pamidronate—osteoporosis	0.000334	0.000742	CcSEcCtD
Vardenafil—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000333	0.000741	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000333	0.00074	CcSEcCtD
Vardenafil—Angioedema—Estradiol—osteoporosis	0.000333	0.00074	CcSEcCtD
Vardenafil—Rash—Calcitriol—osteoporosis	0.000333	0.000739	CcSEcCtD
Vardenafil—Dermatitis—Calcitriol—osteoporosis	0.000332	0.000739	CcSEcCtD
Vardenafil—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000331	0.000736	CcSEcCtD
Vardenafil—Headache—Calcitriol—osteoporosis	0.00033	0.000735	CcSEcCtD
Vardenafil—Somnolence—Conjugated Estrogens—osteoporosis	0.00033	0.000734	CcSEcCtD
Vardenafil—Pain—Zoledronate—osteoporosis	0.00033	0.000733	CcSEcCtD
Vardenafil—Nausea—Alendronate—osteoporosis	0.000329	0.000731	CcSEcCtD
Vardenafil—Malaise—Estradiol—osteoporosis	0.000328	0.00073	CcSEcCtD
Vardenafil—Hypersensitivity—Risedronate—osteoporosis	0.000327	0.000727	CcSEcCtD
Vardenafil—Vertigo—Estradiol—osteoporosis	0.000327	0.000727	CcSEcCtD
Vardenafil—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000327	0.000727	CcSEcCtD
Vardenafil—Asthenia—Ethinyl Estradiol—osteoporosis	0.000327	0.000726	CcSEcCtD
Vardenafil—Syncope—Estradiol—osteoporosis	0.000326	0.000726	CcSEcCtD
Vardenafil—Nausea—Raloxifene—osteoporosis	0.000323	0.000719	CcSEcCtD
Vardenafil—Pruritus—Ethinyl Estradiol—osteoporosis	0.000322	0.000716	CcSEcCtD
Vardenafil—Palpitations—Estradiol—osteoporosis	0.000322	0.000715	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00032	0.000713	CcSEcCtD
Vardenafil—Nausea—Ibandronate—osteoporosis	0.00032	0.000711	CcSEcCtD
Vardenafil—Loss of consciousness—Estradiol—osteoporosis	0.00032	0.000711	CcSEcCtD
Vardenafil—Asthenia—Risedronate—osteoporosis	0.000319	0.000708	CcSEcCtD
Vardenafil—Feeling abnormal—Zoledronate—osteoporosis	0.000318	0.000706	CcSEcCtD
Vardenafil—Pain—Conjugated Estrogens—osteoporosis	0.000317	0.000706	CcSEcCtD
Vardenafil—Gastrointestinal pain—Zoledronate—osteoporosis	0.000315	0.000701	CcSEcCtD
Vardenafil—Pruritus—Risedronate—osteoporosis	0.000314	0.000698	CcSEcCtD
Vardenafil—Nausea—Calcitriol—osteoporosis	0.000313	0.000696	CcSEcCtD
Vardenafil—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000312	0.000693	CcSEcCtD
Vardenafil—Hypersensitivity—Pamidronate—osteoporosis	0.000311	0.000691	CcSEcCtD
Vardenafil—Myalgia—Estradiol—osteoporosis	0.00031	0.000689	CcSEcCtD
Vardenafil—Arthralgia—Estradiol—osteoporosis	0.00031	0.000689	CcSEcCtD
Vardenafil—Chest pain—Estradiol—osteoporosis	0.00031	0.000689	CcSEcCtD
Vardenafil—Anxiety—Estradiol—osteoporosis	0.000309	0.000687	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000308	0.000684	CcSEcCtD
Vardenafil—Discomfort—Estradiol—osteoporosis	0.000306	0.000681	CcSEcCtD
Vardenafil—Abdominal pain—Zoledronate—osteoporosis	0.000305	0.000678	CcSEcCtD
Vardenafil—Diarrhoea—Risedronate—osteoporosis	0.000304	0.000675	CcSEcCtD
Vardenafil—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000304	0.000675	CcSEcCtD
Vardenafil—Dry mouth—Estradiol—osteoporosis	0.000303	0.000674	CcSEcCtD
Vardenafil—Asthenia—Pamidronate—osteoporosis	0.000303	0.000673	CcSEcCtD
Vardenafil—Dizziness—Ethinyl Estradiol—osteoporosis	0.000301	0.00067	CcSEcCtD
Vardenafil—Pruritus—Pamidronate—osteoporosis	0.000299	0.000664	CcSEcCtD
Vardenafil—Anaphylactic shock—Estradiol—osteoporosis	0.000297	0.000661	CcSEcCtD
Vardenafil—Infection—Estradiol—osteoporosis	0.000295	0.000656	CcSEcCtD
Vardenafil—Dizziness—Risedronate—osteoporosis	0.000294	0.000653	CcSEcCtD
Vardenafil—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000293	0.000652	CcSEcCtD
Vardenafil—Shock—Estradiol—osteoporosis	0.000292	0.00065	CcSEcCtD
Vardenafil—Nervous system disorder—Estradiol—osteoporosis	0.000291	0.000648	CcSEcCtD
Vardenafil—Tachycardia—Estradiol—osteoporosis	0.00029	0.000645	CcSEcCtD
Vardenafil—Vomiting—Ethinyl Estradiol—osteoporosis	0.00029	0.000644	CcSEcCtD
Vardenafil—Diarrhoea—Pamidronate—osteoporosis	0.000289	0.000642	CcSEcCtD
Vardenafil—Skin disorder—Estradiol—osteoporosis	0.000289	0.000642	CcSEcCtD
Vardenafil—Hyperhidrosis—Estradiol—osteoporosis	0.000287	0.000639	CcSEcCtD
Vardenafil—Rash—Ethinyl Estradiol—osteoporosis	0.000287	0.000638	CcSEcCtD
Vardenafil—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000287	0.000638	CcSEcCtD
Vardenafil—Headache—Ethinyl Estradiol—osteoporosis	0.000285	0.000634	CcSEcCtD
Vardenafil—Hypersensitivity—Zoledronate—osteoporosis	0.000284	0.000632	CcSEcCtD
Vardenafil—Vomiting—Risedronate—osteoporosis	0.000282	0.000628	CcSEcCtD
Vardenafil—Rash—Risedronate—osteoporosis	0.00028	0.000622	CcSEcCtD
Vardenafil—Dermatitis—Risedronate—osteoporosis	0.00028	0.000622	CcSEcCtD
Vardenafil—Dizziness—Pamidronate—osteoporosis	0.000279	0.000621	CcSEcCtD
Vardenafil—Headache—Risedronate—osteoporosis	0.000278	0.000618	CcSEcCtD
Vardenafil—Asthenia—Zoledronate—osteoporosis	0.000277	0.000615	CcSEcCtD
Vardenafil—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000273	0.000608	CcSEcCtD
Vardenafil—Pruritus—Zoledronate—osteoporosis	0.000273	0.000606	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000271	0.000602	CcSEcCtD
Vardenafil—Nausea—Ethinyl Estradiol—osteoporosis	0.00027	0.000601	CcSEcCtD
Vardenafil—Insomnia—Estradiol—osteoporosis	0.000269	0.000597	CcSEcCtD
Vardenafil—Vomiting—Pamidronate—osteoporosis	0.000268	0.000597	CcSEcCtD
Vardenafil—Paraesthesia—Estradiol—osteoporosis	0.000267	0.000593	CcSEcCtD
Vardenafil—Asthenia—Conjugated Estrogens—osteoporosis	0.000266	0.000592	CcSEcCtD
Vardenafil—Rash—Pamidronate—osteoporosis	0.000266	0.000592	CcSEcCtD
Vardenafil—Dermatitis—Pamidronate—osteoporosis	0.000266	0.000591	CcSEcCtD
Vardenafil—Dyspnoea—Estradiol—osteoporosis	0.000265	0.000589	CcSEcCtD
Vardenafil—Headache—Pamidronate—osteoporosis	0.000264	0.000588	CcSEcCtD
Vardenafil—Somnolence—Estradiol—osteoporosis	0.000264	0.000587	CcSEcCtD
Vardenafil—Diarrhoea—Zoledronate—osteoporosis	0.000264	0.000586	CcSEcCtD
Vardenafil—Nausea—Risedronate—osteoporosis	0.000264	0.000586	CcSEcCtD
Vardenafil—Pruritus—Conjugated Estrogens—osteoporosis	0.000263	0.000584	CcSEcCtD
Vardenafil—Dyspepsia—Estradiol—osteoporosis	0.000262	0.000581	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Estradiol—osteoporosis	0.000256	0.00057	CcSEcCtD
Vardenafil—Dizziness—Zoledronate—osteoporosis	0.000255	0.000567	CcSEcCtD
Vardenafil—Pain—Estradiol—osteoporosis	0.000254	0.000565	CcSEcCtD
Vardenafil—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000254	0.000565	CcSEcCtD
Vardenafil—Nausea—Pamidronate—osteoporosis	0.000251	0.000557	CcSEcCtD
Vardenafil—Dizziness—Conjugated Estrogens—osteoporosis	0.000245	0.000546	CcSEcCtD
Vardenafil—Vomiting—Zoledronate—osteoporosis	0.000245	0.000545	CcSEcCtD
Vardenafil—Feeling abnormal—Estradiol—osteoporosis	0.000245	0.000544	CcSEcCtD
Vardenafil—Rash—Zoledronate—osteoporosis	0.000243	0.00054	CcSEcCtD
Vardenafil—Gastrointestinal pain—Estradiol—osteoporosis	0.000243	0.00054	CcSEcCtD
Vardenafil—Dermatitis—Zoledronate—osteoporosis	0.000243	0.00054	CcSEcCtD
Vardenafil—Headache—Zoledronate—osteoporosis	0.000242	0.000537	CcSEcCtD
Vardenafil—Vomiting—Conjugated Estrogens—osteoporosis	0.000236	0.000525	CcSEcCtD
Vardenafil—Abdominal pain—Estradiol—osteoporosis	0.000235	0.000522	CcSEcCtD
Vardenafil—Rash—Conjugated Estrogens—osteoporosis	0.000234	0.00052	CcSEcCtD
Vardenafil—Dermatitis—Conjugated Estrogens—osteoporosis	0.000234	0.00052	CcSEcCtD
Vardenafil—Headache—Conjugated Estrogens—osteoporosis	0.000233	0.000517	CcSEcCtD
Vardenafil—Nausea—Zoledronate—osteoporosis	0.000229	0.000509	CcSEcCtD
Vardenafil—Nausea—Conjugated Estrogens—osteoporosis	0.00022	0.00049	CcSEcCtD
Vardenafil—Hypersensitivity—Estradiol—osteoporosis	0.000219	0.000487	CcSEcCtD
Vardenafil—Asthenia—Estradiol—osteoporosis	0.000213	0.000474	CcSEcCtD
Vardenafil—Pruritus—Estradiol—osteoporosis	0.00021	0.000467	CcSEcCtD
Vardenafil—Diarrhoea—Estradiol—osteoporosis	0.000203	0.000452	CcSEcCtD
Vardenafil—Dizziness—Estradiol—osteoporosis	0.000196	0.000437	CcSEcCtD
Vardenafil—PDE10A—GPCR downstream signaling—ADCY5—osteoporosis	0.000196	0.00101	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTH1R—osteoporosis	0.000196	0.00101	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CALCR—osteoporosis	0.000196	0.00101	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NFATC1—osteoporosis	0.000194	0.00101	CbGpPWpGaD
Vardenafil—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000194	0.001	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—DKK1—osteoporosis	0.000193	0.000997	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PTH—osteoporosis	0.000192	0.000991	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—WNT1—osteoporosis	0.000191	0.000986	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—IRS1—osteoporosis	0.00019	0.000981	CbGpPWpGaD
Vardenafil—Vomiting—Estradiol—osteoporosis	0.000189	0.00042	CcSEcCtD
Vardenafil—PDE11A—Signaling Pathways—PTHLH—osteoporosis	0.000188	0.000975	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—BMP2—osteoporosis	0.000188	0.000975	CbGpPWpGaD
Vardenafil—Rash—Estradiol—osteoporosis	0.000187	0.000416	CcSEcCtD
Vardenafil—Dermatitis—Estradiol—osteoporosis	0.000187	0.000416	CcSEcCtD
Vardenafil—PDE1B—Immune System—ACTG1—osteoporosis	0.000187	0.000967	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CNR2—osteoporosis	0.000187	0.000965	CbGpPWpGaD
Vardenafil—Headache—Estradiol—osteoporosis	0.000186	0.000414	CcSEcCtD
Vardenafil—PDE10A—Signaling Pathways—WNT1—osteoporosis	0.000186	0.000961	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGA—osteoporosis	0.000185	0.000959	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FGB—osteoporosis	0.000184	0.000954	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	0.000182	0.00094	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—KL—osteoporosis	0.000181	0.000935	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGA—osteoporosis	0.000181	0.000935	CbGpPWpGaD
Vardenafil—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	0.000179	0.000927	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—IL6R—osteoporosis	0.000178	0.000921	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—ADCY5—osteoporosis	0.000178	0.000921	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PSMA2—osteoporosis	0.000178	0.000921	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PSMA5—osteoporosis	0.000178	0.000921	CbGpPWpGaD
Vardenafil—Nausea—Estradiol—osteoporosis	0.000176	0.000392	CcSEcCtD
Vardenafil—PDE1B—Signaling by GPCR—PTH—osteoporosis	0.000174	0.0009	CbGpPWpGaD
Vardenafil—PDE1B—Disease—ACP5—osteoporosis	0.000173	0.000893	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PTHLH—osteoporosis	0.000172	0.000892	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—BMP2—osteoporosis	0.000172	0.000892	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CNR2—osteoporosis	0.000169	0.000877	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGB—osteoporosis	0.000169	0.000873	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PTHLH—osteoporosis	0.000168	0.000869	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—BMP2—osteoporosis	0.000168	0.000869	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CALCA—osteoporosis	0.000166	0.000858	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGB—osteoporosis	0.000164	0.00085	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PSMA2—osteoporosis	0.000163	0.000842	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PSMA5—osteoporosis	0.000163	0.000842	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—POMC—osteoporosis	0.000162	0.000837	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000161	0.000832	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TPI1—osteoporosis	0.00016	0.00083	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—WNT1—osteoporosis	0.000159	0.000824	CbGpPWpGaD
Vardenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000159	0.000823	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PTHLH—osteoporosis	0.000159	0.000821	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PSMA2—osteoporosis	0.000159	0.000821	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PSMA5—osteoporosis	0.000159	0.000821	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000159	0.00082	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—RAP1A—osteoporosis	0.000156	0.000808	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MGLL—osteoporosis	0.000155	0.000804	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CTSK—osteoporosis	0.000155	0.000801	CbGpPWpGaD
Vardenafil—PDE6G—Disease—ADCY5—osteoporosis	0.000154	0.000797	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—NFATC1—osteoporosis	0.000152	0.000788	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CALCA—osteoporosis	0.000152	0.000785	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LRP5—osteoporosis	0.000152	0.000784	CbGpPWpGaD
Vardenafil—PDE1B—Disease—P4HB—osteoporosis	0.000151	0.00078	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—KL—osteoporosis	0.000151	0.000779	CbGpPWpGaD
Vardenafil—PDE1B—Disease—GAPDH—osteoporosis	0.000148	0.000766	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CALCA—osteoporosis	0.000148	0.000765	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—TGFB1—osteoporosis	0.000148	0.000764	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—POMC—osteoporosis	0.000147	0.00076	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LRP6—osteoporosis	0.000145	0.00075	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—POMC—osteoporosis	0.000144	0.000746	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PTHLH—osteoporosis	0.000144	0.000745	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL6R—osteoporosis	0.000143	0.000742	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AGER—osteoporosis	0.000142	0.000735	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MTHFR—osteoporosis	0.000142	0.000733	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—ADCY5—osteoporosis	0.000142	0.000732	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NFATC1—osteoporosis	0.000141	0.000728	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CALCA—osteoporosis	0.00014	0.000723	CbGpPWpGaD
Vardenafil—PDE1B—Disease—DKK1—osteoporosis	0.00014	0.000722	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—KL—osteoporosis	0.000138	0.000713	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IRS2—osteoporosis	0.000135	0.000698	CbGpPWpGaD
Vardenafil—PDE1B—Disease—WNT1—osteoporosis	0.000134	0.000695	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—KL—osteoporosis	0.000134	0.000695	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—IL6—osteoporosis	0.000134	0.000691	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TGFB1—osteoporosis	0.000132	0.000681	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TGFB1—osteoporosis	0.000132	0.000681	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—POMC—osteoporosis	0.000131	0.000678	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGA—osteoporosis	0.000131	0.000676	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL6R—osteoporosis	0.000128	0.000661	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CALCA—osteoporosis	0.000127	0.000656	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—IL6—osteoporosis	0.000126	0.00065	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—IL6—osteoporosis	0.000125	0.000647	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—IL6—osteoporosis	0.000124	0.000643	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PSMA2—osteoporosis	0.000124	0.000643	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PSMA5—osteoporosis	0.000124	0.000643	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IRS2—osteoporosis	0.000124	0.000641	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—IL6—osteoporosis	0.000124	0.00064	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TLN1—osteoporosis	0.000122	0.000634	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ADCY5—osteoporosis	0.000118	0.000611	CbGpPWpGaD
Vardenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000118	0.00061	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IRS1—osteoporosis	0.000118	0.000609	CbGpPWpGaD
Vardenafil—PDE1B—Disease—ENO1—osteoporosis	0.000117	0.000603	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—IL6—osteoporosis	0.000116	0.000602	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—IL6—osteoporosis	0.000116	0.000602	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—IL6—osteoporosis	0.000115	0.000597	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PSMA2—osteoporosis	0.000115	0.000594	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PSMA5—osteoporosis	0.000115	0.000594	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—IL6—osteoporosis	0.000114	0.000592	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SPP1—osteoporosis	0.000114	0.000591	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—IL6—osteoporosis	0.000114	0.000589	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—IGF1—osteoporosis	0.000111	0.000576	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6R—osteoporosis	0.000111	0.000572	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—POMC—osteoporosis	0.000109	0.000565	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IRS1—osteoporosis	0.000108	0.000559	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ADCY5—osteoporosis	0.000108	0.000558	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CALCA—osteoporosis	0.000107	0.000554	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—P4HB—osteoporosis	0.000106	0.000546	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—KL—osteoporosis	0.000105	0.000545	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ADCY5—osteoporosis	0.000105	0.000544	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SPP1—osteoporosis	0.000104	0.00054	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IRS2—osteoporosis	0.000103	0.000534	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	0.000103	0.000534	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PKM—osteoporosis	0.000103	0.000533	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—FDPS—osteoporosis	0.000103	0.000533	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTH—osteoporosis	0.000103	0.000531	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SPP1—osteoporosis	0.000102	0.000526	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6R—osteoporosis	0.000102	0.000525	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—LEP—osteoporosis	0.000101	0.000523	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RAP1A—osteoporosis	0.000101	0.000522	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CNR2—osteoporosis	0.0001	0.000518	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—ADCY5—osteoporosis	9.94e-05	0.000514	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NFATC1—osteoporosis	9.85e-05	0.00051	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—DKK1—osteoporosis	9.77e-05	0.000506	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GPD2—osteoporosis	9.76e-05	0.000505	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PGLS—osteoporosis	9.76e-05	0.000505	CbGpPWpGaD
Vardenafil—PDE1B—Disease—KL—osteoporosis	9.72e-05	0.000503	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ESR1—osteoporosis	9.65e-05	0.000499	CbGpPWpGaD
Vardenafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.56e-05	0.000494	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IRS2—osteoporosis	9.45e-05	0.000489	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—WNT1—osteoporosis	9.41e-05	0.000487	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—LEP—osteoporosis	9.24e-05	0.000478	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IRS2—osteoporosis	9.2e-05	0.000476	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGA—osteoporosis	9.16e-05	0.000474	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—ADCY5—osteoporosis	9.03e-05	0.000467	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IRS1—osteoporosis	9.02e-05	0.000466	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—LEP—osteoporosis	9.01e-05	0.000466	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ATIC—osteoporosis	8.93e-05	0.000462	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PNP—osteoporosis	8.93e-05	0.000462	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ESR1—osteoporosis	8.82e-05	0.000456	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—POMC—osteoporosis	8.68e-05	0.000449	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ESR1—osteoporosis	8.6e-05	0.000445	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTHLH—osteoporosis	8.51e-05	0.00044	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BMP2—osteoporosis	8.51e-05	0.00044	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6R—osteoporosis	8.47e-05	0.000438	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	8.45e-05	0.000437	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IGF1—osteoporosis	8.35e-05	0.000432	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	8.33e-05	0.000431	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGB—osteoporosis	8.33e-05	0.000431	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AGER—osteoporosis	8.27e-05	0.000428	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—ADCY5—osteoporosis	8.25e-05	0.000427	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IRS1—osteoporosis	8.25e-05	0.000426	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PSMA2—osteoporosis	8.04e-05	0.000416	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PSMA5—osteoporosis	8.04e-05	0.000416	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IRS1—osteoporosis	8.04e-05	0.000416	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—POMC—osteoporosis	7.94e-05	0.000411	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—IL6—osteoporosis	7.93e-05	0.00041	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6R—osteoporosis	7.75e-05	0.000401	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—POMC—osteoporosis	7.74e-05	0.0004	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IGF1—osteoporosis	7.64e-05	0.000395	CbGpPWpGaD
Vardenafil—PDE1B—Disease—ADCY5—osteoporosis	7.61e-05	0.000394	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CA2—osteoporosis	7.59e-05	0.000393	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—OXCT1—osteoporosis	7.59e-05	0.000393	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6R—osteoporosis	7.55e-05	0.00039	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CALCA—osteoporosis	7.5e-05	0.000388	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IGF1—osteoporosis	7.44e-05	0.000385	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MGLL—osteoporosis	7.4e-05	0.000383	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—POMC—osteoporosis	7.31e-05	0.000378	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IRS2—osteoporosis	7.22e-05	0.000373	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTHFR—osteoporosis	7e-05	0.000362	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KL—osteoporosis	6.81e-05	0.000352	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TGFB1—osteoporosis	6.67e-05	0.000345	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IRS2—osteoporosis	6.66e-05	0.000345	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—POMC—osteoporosis	6.64e-05	0.000343	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MYC—osteoporosis	6.55e-05	0.000339	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TGFB1—osteoporosis	6.54e-05	0.000338	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6R—osteoporosis	6.48e-05	0.000335	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL6—osteoporosis	6.39e-05	0.00033	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IRS1—osteoporosis	6.3e-05	0.000326	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—IDH2—osteoporosis	6.29e-05	0.000325	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6R—osteoporosis	5.92e-05	0.000306	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP27A1—osteoporosis	5.92e-05	0.000306	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IRS1—osteoporosis	5.82e-05	0.000301	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ACP5—osteoporosis	5.75e-05	0.000298	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL6—osteoporosis	5.69e-05	0.000294	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6R—osteoporosis	5.46e-05	0.000283	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TPI1—osteoporosis	5.35e-05	0.000277	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ADCY5—osteoporosis	5.33e-05	0.000276	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SPP1—osteoporosis	5.16e-05	0.000267	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—POMC—osteoporosis	5.08e-05	0.000263	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—P4HB—osteoporosis	5.03e-05	0.00026	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MYC—osteoporosis	5.02e-05	0.00026	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—osteoporosis	5.01e-05	0.000259	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GAPDH—osteoporosis	4.94e-05	0.000255	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6—osteoporosis	4.93e-05	0.000255	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—RAP1A—osteoporosis	4.81e-05	0.000249	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PKM—osteoporosis	4.79e-05	0.000248	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—FDPS—osteoporosis	4.79e-05	0.000248	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IRS2—osteoporosis	4.66e-05	0.000241	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MYC—osteoporosis	4.59e-05	0.000237	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—osteoporosis	4.58e-05	0.000237	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LEP—osteoporosis	4.57e-05	0.000236	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPD2—osteoporosis	4.54e-05	0.000235	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PGLS—osteoporosis	4.54e-05	0.000235	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6—osteoporosis	4.53e-05	0.000234	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1B—osteoporosis	4.5e-05	0.000233	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MYC—osteoporosis	4.47e-05	0.000231	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—osteoporosis	4.46e-05	0.000231	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ESR1—osteoporosis	4.36e-05	0.000225	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PNP—osteoporosis	4.15e-05	0.000215	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ATIC—osteoporosis	4.15e-05	0.000215	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IRS1—osteoporosis	4.07e-05	0.000211	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—POMC—osteoporosis	3.92e-05	0.000203	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ENO1—osteoporosis	3.89e-05	0.000201	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PSMA2—osteoporosis	3.83e-05	0.000198	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PSMA5—osteoporosis	3.83e-05	0.000198	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6R—osteoporosis	3.83e-05	0.000198	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6—osteoporosis	3.77e-05	0.000195	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF1—osteoporosis	3.77e-05	0.000195	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CA2—osteoporosis	3.53e-05	0.000183	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—OXCT1—osteoporosis	3.53e-05	0.000183	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6—osteoporosis	3.45e-05	0.000178	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MGLL—osteoporosis	3.44e-05	0.000178	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6—osteoporosis	3.36e-05	0.000174	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MYC—osteoporosis	3.24e-05	0.000167	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—osteoporosis	3.23e-05	0.000167	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP19A1—osteoporosis	3.11e-05	0.000161	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—IDH2—osteoporosis	2.93e-05	0.000151	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6—osteoporosis	2.88e-05	0.000149	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.75e-05	0.000142	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ACP5—osteoporosis	2.68e-05	0.000138	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6—osteoporosis	2.64e-05	0.000136	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ADCY5—osteoporosis	2.54e-05	0.000131	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GPX1—osteoporosis	2.53e-05	0.000131	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TPI1—osteoporosis	2.49e-05	0.000129	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6—osteoporosis	2.43e-05	0.000126	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—P4HB—osteoporosis	2.34e-05	0.000121	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTHFR—osteoporosis	2.34e-05	0.000121	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GAPDH—osteoporosis	2.3e-05	0.000119	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MYC—osteoporosis	2.27e-05	0.000117	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—osteoporosis	2.26e-05	0.000117	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—RAP1A—osteoporosis	2.24e-05	0.000116	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—POMC—osteoporosis	1.87e-05	9.66e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ENO1—osteoporosis	1.81e-05	9.35e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PSMA2—osteoporosis	1.78e-05	9.21e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PSMA5—osteoporosis	1.78e-05	9.21e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6—osteoporosis	1.7e-05	8.81e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.44e-05	7.47e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ADCY5—osteoporosis	1.18e-05	6.11e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPX1—osteoporosis	1.18e-05	6.08e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTHFR—osteoporosis	1.09e-05	5.62e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—POMC—osteoporosis	8.68e-06	4.49e-05	CbGpPWpGaD
